Sealife in Seattle is testing positive for opioids

The nation's opioid crisis isn't limited to the landbound.
Scientists near Seattle, Washington, found that some marine creatures have absorbed drugs that end up in the waters due to human drug use, KIRO News reported Thursday.
When looking for water contamination, scientists found that mussels in the Puget Sound tested positive for oxycodone and other chemicals. Sealife can get contaminated when humans ingest opioids, because people later excrete trace amounts of drugs, which end up in wastewater. The wastewater is cleaned, but not all drugs can be filtered out.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“It's telling me there's a lot of people taking oxycodone in the Puget Sound area,” one researcher told KIRO.
Researchers found that mussels in multiple locations had absorbed not only opioids, but also antibiotics and other prescription drugs. Washington officials said that the contamination shouldn't make it unsafe to eat mussels, since shellfish in restaurants are coming from different areas. Read more at KIRO News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Summer Meza has worked at The Week since 2018, serving as a staff writer, a news writer and currently the deputy editor. As a proud news generalist, she edits everything from political punditry and science news to personal finance advice and film reviews. Summer has previously written for Newsweek and the Seattle Post-Intelligencer, covering national politics, transportation and the cannabis industry.
-
'The Postal Service has bound our nation together'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
ICE arrests Palestinian advocate with green card
Speed Read Recent Columbia University graduate student Mahmoud Khalil has had his visa revoked, despite his status as a permanent resident
By Peter Weber, The Week US Published
-
Trump doesn't rule out recession as tariffs bite
Speed Read In an interview for Fox News, Trump acknowledges the economic turbulence caused by his tariffs but claims his policies will be worth it in the long run
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published